focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtalaya Mining Regulatory News (ATYM)

Share Price Information for Atalaya Mining (ATYM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 480.00
Bid: 478.50
Ask: 483.00
Change: 20.00 (4.35%)
Spread: 4.50 (0.94%)
Open: 460.00
High: 481.50
Low: 455.00
Prev. Close: 460.00
ATYM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Files Final Prospectus & Announces Terms of Offer

14 Dec 2010 07:00

RNS Number : 8929X
EMED Mining Public Limited
14 December 2010
 



AIM: EMED 14 December 2010

NOT TO BE DISTRIBUTED TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATED IN THE UNITED STATES

 

EMED Mining Files Final Prospectus and Announces Terms of Offering

 

EMED Mining Public Limited ("EMED Mining" or the "Company") is pleased to announce that it has obtained a receipt for a final prospectus in connection with its previously announced initial public offering in Canada (the "Canadian Offering") of ordinary shares (the "Ordinary Shares"), which final prospectus qualifies the issue of up to 180,970,000 Ordinary Shares at an issue price of CAD$0.135 (approximately 8.5 pence based on an exchange rate of CAD$1.00 = GBP£0.6268) (the "Issue Price") per Ordinary Share for aggregate gross proceeds of up to CAD$24,430,950 (approximately GBP£15,313,320). The Canadian Offering is being made in conjunction with a listing of the Ordinary Shares (the "Listing") on the Toronto Stock Exchange (the "TSX") and is being led by Canaccord Genuity Corp. with a syndicate of agents that includes GMP Securities L.P. and Paradigm Capital Inc. (collectively, the "Canadian Agents"). The Company has also granted the Canadian Agents an option to purchase up to that number of additional Ordinary Shares at the Issue Price as is equal to 15% of the number of Ordinary Shares sold pursuant to the Canadian Offering, exercisable at any time for a period of 30 days from and including the date of the closing of the Canadian Offering (the "Over-allotment Option").

 

Concurrent with the closing of the Canadian Offering, the Company is proposing to complete a private placement of Ordinary Shares, principally in the UK, at an issue price of 8.5 pence (GBP£) (being approximately CAD$0.135) per Ordinary Share (the "UK Offering"). Fox-Davies Capital Limited and Fairfax I.S. plc will act as brokers to the UK Offering. The definitive number of shares to be issued in connection with UK Offering shall be settled based on the number of Ordinary Shares issued in connection with the Canadian Offering. The Company shall not issue greater than an aggregate of 259,241,886Ordinary Shares in connection with the UK Offering and the Canadian Offering and accordingly, the aggregate gross proceeds of the Canadian Offering and the UK Offering will not exceed CAD$35 million (approximately GBP£22 million) (which includes the exercise of the Over-allotment Option).

 

Both the Canadian Offering and the UK Offering are expected to close on or about Monday, December 20, 2010.

 

The Company has received conditional approval for the Listing. The Ordinary Shares will trade on the TSX under the symbol "EMD". The Listing is subject to the Company fulfilling all of the requirements of the TSX, including distribution of the Ordinary Shares to a minimum number of public holders.

 

The pricing of the share offerings represents a discount of 8.3% against the volume weighted average market price of the Company's ordinary shares of 9.27 pence on AIM since the filing of the preliminary prospectus on October 19, 2010.

 

The Ordinary Shares will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. No securities commission has approved or disapproved the contents of this press release. 

 

A copy of the final prospectus will be available on SEDAR (www.sedar.com) or by contacting the Company or Canaccord Genuity Corp. at the below numbers.

 

Enquiries

 

EMED Mining

Harry Anagnostaras-Adams

+357 9945 7843

RFC Corporate Finance

Stuart Laing

+61 8 9480 2500

Fox-Davies Capital

Simon Leathers

+44 203 463 5022

Fairfax I.S. PLC

Ewan Leggat/Katy Birkin

+44 207 598 5368

Canaccord Genuity

Craig Warren

+1 416 869 7316

Bishopsgate Communications

Michael Kinirons

+44 207 562 3350

Proconsul Capital

Andreas Curkovic

+1 416 577 9927

 

 

For further information on the Company's activities, visit www.emed-mining.com or www.emed.tv

 

Forward Looking Information

This press release contains "forward-looking information" which may include, but is not limited to, statements with respect to the closing of the Canadian and UK Offering, the future financial or operating performance of the Company, its subsidiaries, future growth, results of operations, performance, business prospects and opportunities. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "believes", or variations (including negative variations) of such words and phrases, or by the use of words or phrases that state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company and/or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements contained in this press release including, without limitation those described in the final prospectus under the heading "Risk Factors". Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in such forward-looking statements, there may be other factors that may cause actions, events or results to differ from those anticipated, estimated or intended. Should one or more of these risks or uncertainties materialize or should assumptions underlying such forward-looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this press release. The forward-looking information and forward-looking statements contained herein are made as of the date of this press release and the company disclaims any obligation to update or review such information or statements, whether as a result of new information, future events or results of otherwise, except as required by law.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMMZVDNGGZG
Date   Source Headline
17th Jan 20177:00 amRNS2016 Operations Update
19th Dec 20167:00 amRNSNameplate Capacity Achieved
24th Nov 20167:00 amRNSOperational Review and Q3 Financials
11th Oct 20167:00 amRNSOperations Update
29th Sep 20164:05 pmRNSFiling of NI 43-101 Technical Report
7th Sep 20167:00 amRNSHalf-year Report
5th Sep 20167:00 amRNSUS$14 million Prepayment Funding with Transamine
25th Jul 20167:00 amRNSOperations Update
14th Jul 20167:00 amRNSUpdated Reserves and Resources Statement
7th Jul 20161:34 pmRNSResult of AGM
7th Jul 20167:01 amRNSAGM Statement
7th Jul 20167:00 amRNSAppointment of Group Chief Financial Officer
24th Jun 20168:03 amRNSAppointment of Joint Corporate Broker
13th Jun 20167:00 amRNSNotice of AGM
26th May 20167:00 amRNSEarly Commissioning of Expansion & Q1 Financials
4th May 20167:00 amRNSUpdate on plant re-start and commissioning
22nd Apr 20162:34 pmRNSTemporary Suspension of usage of Tailings Facility
22nd Apr 20167:00 amRNSFinal Results
14th Apr 20167:00 amRNSOperations Update
26th Jan 20167:00 amRNSHolding(s) in Company
15th Jan 20167:00 amRNSDeclaration of Commercial Production
26th Nov 20157:00 amRNSOperations Update & Quarterly Financial Statements
2nd Nov 20157:00 amRNSReceipt of Claim from Astor Management AG
21st Oct 20157:00 amRNSChange of Name and Share Consolidation
13th Oct 20151:10 pmRNSResult of EGM
11th Sep 20159:00 amRNSProposed Consolidation of Shares and Name Change
10th Sep 20157:00 amRNSHalf Yearly Report
7th Sep 20157:00 amRNSDirector Appointments
2nd Sep 20157:00 amRNSOperations Update
29th Jul 201512:13 pmRNSResult of AGM
29th Jul 201510:00 amRNSAGM Statement
16th Jul 20157:00 amRNSAward of Municipal Activity Licence
9th Jul 20157:00 amRNSManagement Update
6th Jul 20157:00 amRNSNotice of AGM
3rd Jul 201510:48 amRNSDirector Share Purchase
1st Jul 20157:00 amRNSQuarterly Financial Statements
30th Jun 20152:30 pmRNSPosting of Annual Report
24th Jun 20157:00 amRNSRevised Admission Date
23rd Jun 20153:12 pmRNSResult of EGM and Appointment of Director
23rd Jun 201510:36 amRNSResult of Rump Placing
22nd Jun 20157:00 amRNSRESULT OF OPEN OFFER
16th Jun 201511:46 amRNSNew Investment - EMED Mining Public Limited
12th Jun 20157:00 amRNSResult of Placing
29th May 20155:05 pmRNSPosting of Circular and Notice of EGM
28th May 20154:30 pmRNSSubscription, Placing and Open Offer
20th May 20159:18 amRNSFinancing Update
8th May 20155:08 pmRNSFinal Results
5th May 201510:04 amRNSFinancing Update and Notice of Results
7th Apr 20153:00 pmRNSFurther US$6m from Unsecured Bridging Finance
30th Mar 20157:00 amRNSLoan and Convertible Note Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.